Funds and ETFs Hua Medicine (Shanghai) Ltd.
Equities
2552
KYG4644K1022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 HKD | -3.05% | -.--% | -19.29% |
28/03 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
ETFs positioned on Hua Medicine (Shanghai) Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.66% | 4 M€ | -27.92% | ||
0.00% | 117 M€ | -0.10% | - | |
0.00% | 4 M€ | -4.41% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.29% | 199M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- 2552 Stock
- Funds and ETFs Hua Medicine (Shanghai) Ltd.